Sun Yat-sen University: Esophageal Neoplasms trials

The registry lists 23 Esophageal Neoplasms studies with Sun Yat-sen University as lead sponsor. 9 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 6Phase 3 6Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After First-Line Chemoimmunotherapy in Advanced ESCC (Esophageal Squamous Cell Carcinoma)RecruitingNCT07863141Phase 2
• Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical EsophagectomyRecruitingNCT07309991
• Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCCRecruitingNCT07177794Phase 3
• Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown EsophagectomyRecruitingNCT07043491
• Hematoporphyrin Photodynamic Therapy for Esophageal CancerEnrolling by invitationNCT06437288Phase 4
• Submucosal Saline Injection Followed by Endoscopic UltrasoundRecruitingNCT06022978Not applicable
• The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.RecruitingNCT06019455
• Neoadjuvant Toripalimab for dMMR/MSI-H Gastric CancerRecruitingNCT05994456Phase 2
• PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)RecruitingNCT05357846Phase 3
• A Single-center, Single-arm Clinical Study Evaluating the Short-term Efficacy of Inflatable Mediastinoscopic-assisted Transhiatal Laparoscopic Esophagectomy for the Radical Resection of Thoracic Esophageal CancerCompletedNCT07581236Not applicable
• Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)Active, not recruitingNCT06143748Phase 2
• Follow-up Strategy for Esophageal Cancer PatientsStatus unknownNCT06045715
• The Efficacy of Immunodetection Point Inhibitors for Advanced Esophageal CancerStatus unknownNCT04074447
• IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer PatientsStatus unknownNCT03910634Phase 2
• Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed ChemotherapyStatus unknownNCT03811379Phase 2
• Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC PatientsStatus unknownNCT03002064Phase 3
• Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal CarcinomaCompletedNCT02861690Phase 2
• The Clinical Physics Research of Image Guided Adaptive Radiation Therapy for Esophagus CancerStatus unknownNCT02653521Not applicable
• Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)Active, not recruitingNCT02465736Phase 3
• ESI With EUS to Differentiate T3 and T4 ESCCStatus unknownNCT01930630Phase 1
• Endoscopic Ultrasound Plus Submucosal Injection for Early Esophageal CancerStatus unknownNCT01555801Not applicable
• Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal CancerStatus unknownNCT01216527Phase 3
• Improve the Treatment of Thoracic Esophageal CancerCompletedNCT01137123Phase 3